Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Indazole derivatives as novel bradykinin B1 receptor antagonistsVera Bodmer-Narkevitch, Neville J Anthony, Victoria Cofre, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsPaul J Coleman, John D Schreier, Georgia B McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-onesP G Nantermet, J C Barrow, H G Selnick, et al.
Ophthalmology and Therapy|March 25, 2025
Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY StudyIqbal Ike K Ahmed, John P Berdahl, Arkadiy Yadgarov, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activityDong-Mei Feng, Robert M DiPardo, Jenny M Wai, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Pageof 17